
GE Healthcare Technologies Inc
NASDAQ:GEHC

Gross Margin
GE Healthcare Technologies Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
US |
![]() |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.7B USD |
42%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
232.9B USD |
56%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
201.2B USD |
67%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
152.1B USD |
69%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
147.6B USD |
65%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
111.5B USD |
66%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52B EUR |
39%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
49.6B USD |
45%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
45.7B USD |
79%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.4B USD |
61%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
281.9B CNY |
61%
|
GE Healthcare Technologies Inc
Glance View
GE Healthcare Technologies Inc. operates as a pivotal player in the vast landscape of medical technology, skillfully weaving a narrative that integrates cutting-edge innovation with practical application. As a segment originally spun out from the iconic General Electric Company, GE Healthcare focuses on enhancing diagnostics and patient care through its advanced imaging and monitoring systems. The company's portfolio spans a wide range of products, including magnetic resonance imaging (MRI) machines, ultrasound devices, and computed tomography (CT) scanners, each designed to provide medical professionals with critical insights needed for accurate diagnosis and effective treatment. By leveraging decades of engineering expertise and a rich history in innovation, GE Healthcare not only improves hospital efficiencies but also supports personalized healthcare solutions that help in the early detection and effective management of diseases. Their revenue model is primarily centered around the sale of these high-technology machines and the accompanying service agreements that ensure their seamless operation. Additionally, the company generates income from its work in life sciences, offering a suite of applications and software that assist in drug discovery and bioprocessing. Combining hardware sales with recurring revenue streams from maintenance services and digital solutions enhances the company’s financial stability. This multifaceted approach positions GE Healthcare as both a stalwart in existing medical technology fields and a pioneer exploring the frontiers of healthcare innovations, driven by a mission to improve patient outcomes worldwide.

See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on GE Healthcare Technologies Inc's most recent financial statements, the company has Gross Margin of 42%.